Sign inGet started

Brosgart Carol L

Insider CIK 1614724 · TBRA Director · ENOB Director · MIRM Director

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
RENB RENOVARO INC. A Award deriv2024-06-252024-06-2742,857— $042,857SEC↗
RENB RENOVARO INC. A Award deriv2023-12-272024-02-2823,810— $023,810SEC↗
ENOB Enochian Biosciences Inc A Award deriv2022-12-272023-01-0557,252— $057,252SEC↗
MIRM Mirum Pharmaceuticals, Inc A Award deriv2022-06-022022-06-0615,583— $015,583SEC↗
ENOB Enochian Biosciences Inc A Award deriv2021-12-272022-01-039,458— $09,458SEC↗
MIRM Mirum Pharmaceuticals, Inc A Award deriv2021-06-042021-06-0834,000— $034,000SEC↗
ENOB Enochian Biosciences Inc A Award deriv2020-12-282021-12-2125,424— $025,424SEC↗
ENOB Enochian Biosciences Inc A Award deriv2020-04-062021-12-2115,625— $015,625SEC↗
TBRA Tobira Therapeutics, Inc. D To issuer deriv2016-11-012016-11-034,332— $00SEC↗
TBRA Tobira Therapeutics, Inc. D To issuer deriv2016-11-012016-11-034,332— $00SEC↗
TBRA Tobira Therapeutics, Inc. D To issuer deriv2016-11-012016-11-0318,956— $00SEC↗
TBRA Tobira Therapeutics, Inc. D To issuer deriv2016-11-012016-11-0315,500— $00SEC↗
TBRA Tobira Therapeutics, Inc. D To issuer deriv2016-11-012016-11-0317,778— $00SEC↗
TBRA Tobira Therapeutics, Inc. A Award deriv2016-01-122016-01-1417,778— $017,778SEC↗
TBRA Tobira Therapeutics, Inc. A Award deriv2015-07-092015-07-1315,500— $015,500SEC↗
TBRA Tibira Therapeutics, Inc. A Award deriv2015-05-042015-05-064,332— $012,996SEC↗
TBRA Tibira Therapeutics, Inc. A Award deriv2015-05-042015-05-064,332— $08,664SEC↗
TBRA Tibira Therapeutics, Inc. A Award deriv2015-05-042015-05-064,332— $04,332SEC↗
TBRA Tibira Therapeutics, Inc. A Award deriv2015-05-042015-05-0618,956— $031,952SEC↗